119 related articles for article (PubMed ID: 29230839)
1. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
G Thomas E; B Peskoe S; Spiegelman D
Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
[TBL] [Abstract][Full Text] [Related]
2. Estimation of prevalence on the basis of screening tests.
Lew RA; Levy PS
Stat Med; 1989 Oct; 8(10):1225-30. PubMed ID: 2814071
[TBL] [Abstract][Full Text] [Related]
3. Bayesian inference on prevalence using a missing-data approach with simulation-based techniques: applications to HIV screening.
Mendoza-Blanco JR; Tu XM; Iyengar S
Stat Med; 1996 Oct; 15(20):2161-76. PubMed ID: 8910961
[TBL] [Abstract][Full Text] [Related]
4. Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.
Chu H; Cole SR
Biom J; 2006 Aug; 48(5):772-9. PubMed ID: 17094342
[TBL] [Abstract][Full Text] [Related]
5. Studies of AIDS and HIV surveillance. Screening tests: can we get more by doing less?
Tu XM; Litvak E; Pagano M
Stat Med; 1994 Oct 15-30; 13(19-20):1905-19. PubMed ID: 7846399
[TBL] [Abstract][Full Text] [Related]
6. Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers.
Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
Int J Epidemiol; 2019 Dec; 48(6):1795-1803. PubMed ID: 31074780
[TBL] [Abstract][Full Text] [Related]
7. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
8. On the estimation of disease prevalence by latent class models for screening studies using two screening tests with categorical disease status verified in test positives only.
Chu H; Zhou Y; Cole SR; Ibrahim JG
Stat Med; 2010 May; 29(11):1206-18. PubMed ID: 20191614
[TBL] [Abstract][Full Text] [Related]
9. On the use of adjusted cross-sectional estimators of HIV incidence.
Wang R; Lagakos SW
J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
[TBL] [Abstract][Full Text] [Related]
10. Estimating diagnostic accuracy of multiple binary tests with an imperfect reference standard.
Albert PS
Stat Med; 2009 Feb; 28(5):780-97. PubMed ID: 19101935
[TBL] [Abstract][Full Text] [Related]
11. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown.
Enøe C; Georgiadis MP; Johnson WO
Prev Vet Med; 2000 May; 45(1-2):61-81. PubMed ID: 10802334
[TBL] [Abstract][Full Text] [Related]
12. An Adaptive Approach to Locating Mobile HIV Testing Services.
Gonsalves GS; Crawford FW; Cleary PD; Kaplan EH; Paltiel AD
Med Decis Making; 2018 Feb; 38(2):262-272. PubMed ID: 28699382
[TBL] [Abstract][Full Text] [Related]
13. Using interviewer random effects to remove selection bias from HIV prevalence estimates.
McGovern ME; Bärnighausen T; Salomon JA; Canning D
BMC Med Res Methodol; 2015 Feb; 15():8. PubMed ID: 25656226
[TBL] [Abstract][Full Text] [Related]
14. Dual screening.
Johnson WO; Pearson LM
Biometrics; 1999 Sep; 55(3):867-73. PubMed ID: 11315019
[TBL] [Abstract][Full Text] [Related]
15. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center data.
Stock EM; Stamey JD; Sankaranarayanan R; Young DM; Muwonge R; Arbyn M
Cancer Epidemiol; 2012 Apr; 36(2):153-60. PubMed ID: 21856264
[TBL] [Abstract][Full Text] [Related]
16. Bayesian analysis of prevalence with covariates using simulation-based techniques: applications to HIV screening.
Tu XM; Kowalski J; Jia G
Stat Med; 1999 Nov; 18(22):3059-73. PubMed ID: 10544306
[TBL] [Abstract][Full Text] [Related]
17. Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies.
Zhang Z; Liu C; Kim S; Liu A
Stat Med; 2014 Nov; 33(25):4482-500. PubMed ID: 25043925
[TBL] [Abstract][Full Text] [Related]
18. Estimating the number of Cubans infected sexually by human immunodeficiency virus using contact tracing data.
Hsieh YH; de Arazoza H; Lee SM; Chen CW
Int J Epidemiol; 2002 Jun; 31(3):679-83. PubMed ID: 12055173
[TBL] [Abstract][Full Text] [Related]
19. Adjusting for time-dependent sensitivity in an illness-death model, with application to mother-to-child transmission of HIV.
Teeple EA; Brown ER
Stat Med; 2015 Apr; 34(8):1277-92. PubMed ID: 25546029
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
